United States Sleep Apnea Devices Market Analysis Report 2024-2030 Featuring ResMed, Carefusion, Somnomed, Koninklijke Philips, Compumedics, Natus Medical, Teleflex, and Fisher & Paykel Healthcare – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “United States Sleep Apnea Devices Market, Size, Share, Forecast 2024-2030, Industry Trends, Growth, Insight, Types, Therapeutic Devices, Diagnostic Devices, End User, Countries and Company Analysis” report has been added to ResearchAndMarkets.com’s offering.


The United States Sleep Apnea Device Market is projected to expand from US$ 2.02 Billion in 2023 to a staggering US$ 3.76 Billion by 2032, demonstrating a robust CAGR of 7.12% during the period 2023-2032.

The market’s upward trajectory is propelled by several factors, including the increasing prevalence of sleep apnea and rising awareness about the condition. However, the most significant driver is the continuous stream of technological advancements in sleep apnea devices. These innovations enhance the quality of life for sleep apnea patients and fuel the growth of the USA sleep apnea market, which is poised for substantial expansion in the foreseeable future.

The demand for sleep apnea devices is increasing due to the rising number of diagnosed cases of obstructive sleep apnea (OSA). A wide range of options is available, each designed to cater to specific patient needs. These include CPAP machines, oral appliances, and adaptive servo-ventilation devices. The introduction of advanced, user-friendly devices that offer improved comfort and efficacy is a key driver of market growth.

The sleep apnea devices market in the USA is driven significantly by the aging population, which is at the highest risk of developing this disorder. The number of United States Americans aged 65 and older is predicted to reach 82 million by 2050 from 58 million in 2022. Additionally, the share of the total population represented by the 65-and-older age group is projected to rise from 17% to 23%.

More than 5.8 Million adults in the United States are accurately diagnosed with sleep apnea disease. Companies continually invest in R&D to improve device efficacy, comfort, and use. Partnerships and collaborations with healthcare providers and technical innovators are also becoming more frequent tactics for expanding market reach and providing comprehensive solutions.

Home care settings and individuals have a subnational market revenue

Home care settings and individuals are major end users of sleep apnea products in the United States, such as CPAP machines allowing for home therapy. This trend in healthcare towards home-based treatment enables people to manage their conditions without frequent hospitalization or clinic visits, improving compliance and long-term treatment plan adherence.

Many insurance policies cover sleep apnea equipment for home use, making it more affordable. Using the equipment at home helps patients integrate therapy into their daily activities, promoting consistent use and improving treatment outcomes. In the United States, the American Sleep Apnea Association is a non-profit organization that raises awareness about sleep apnea, improves treatments, and advocates for the interests of sleep apnea patients.

United States Pulse Oximeters Market

Pulse oximeters are commonly used in healthcare to measure hemoglobin oxygen saturation. They are noninvasive and convenient, making them widely used in hospitals. The Pulse oximeters segment is expected to rise due to the increasing prevalence of sleep apnea in the USA. Ongoing developments, such as product launches and partnerships, will further boost the segment.

Key Attributes:

Report Attribute
Details

No. of Pages
100

Forecast Period
2023 – 2032

Estimated Market Value (USD) in 2023
$2.02 Billion

Forecasted Market Value (USD) by 2032
$3.76 Billion

Compound Annual Growth Rate
7.1%

Regions Covered
United States

Company Analysis: Overview, Recent Developments, Financial Insight

ResMed Inc.

Carefusion Corp

Somnomed

Koninklijke Philips N.V.

Compumedics

Natus Medical Incorporated

Teleflex Incorporated

Fisher & Paykel Healthcare

Types – Market breakup from 2 viewpoints

Therapeutic Devices

Diagnostic Devices

Therapeutic Devices – Market have been further sub segmented from 4 viewpoints

CPAP Sleep Apnea Therapeutic Devices

Auto CPAP Sleep Apnea Therapeutic Devices

BiPAP Sleep Apnea Therapeutic Devices

Adaptive Servo-Ventilation (ASV)

Diagnostic Devices – Market have been further sub segmented from 5 viewpoints

Polysomnography Devices (PSG)

Oximeter

Actigraphy Monitoring Device

Respiratory Polygraph

Sleep Apnea Screening Device

End User – Market breakup from 2 viewpoints

Sleep Laboratories, Clinics & Hospitals

Home Care Settings/Individuals

For more information about this report visit https://www.researchandmarkets.com/r/er94mx

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Subscribe on LinkedIn

Get the free newsletter

Subscribe to MedicaEx for top news, trends & analysis

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Businesswire is solely responsible for the content of the above news submissions. If there are any violations of laws, violations of the membership terms of this website, or the risk of infringing on the rights of third parties, businesswire will be solely responsible for legal and damage compensation. Responsibility has nothing to do with MedicaEx.

Are you in?

Subscribe to receive exclusive content and notifications to your inbox

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.